Physician profile
Veneah Hall
NPI 1144702226
$297.96
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49.73 | 2021 | |
| Exeltis, USA INC. | $37.80 | 2021 | |
| Ethicon US, LLC | $35.96 | 2021 | |
| Pfizer INC. | $33.75 | 2021 | |
| Axonics, INC. | $32.25 | 2021 | |
| Astellas Pharma US INC | $23.00 | 2021 | |
| Daiichi Sankyo INC. | $22.86 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $21.53 | 2021 | |
| Mylan Pharmaceuticals INC. | $16.74 | 2021 | |
| Avion Pharmaceuticals | $12.48 | 2021 | |
| Therapeuticsmd, INC. | $11.86 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veneah Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.